ZYME
Zymeworks Inc. Common Stock
NASDAQ: ZYME · HEALTHCARE · BIOTECHNOLOGY
$27.83
-0.39% today
Updated 2026-04-29
Market cap
$2.07B
P/E ratio
—
P/S ratio
19.51x
EPS (TTM)
$-1.08
Dividend yield
—
52W range
$11 – $30
Volume
0.7M
Zymeworks Inc. Common Stock (ZYME) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.67M | $9.66M | $11.01M | $51.76M | $53.02M | $29.54M | $38.95M | $26.68M | $412.48M | $76.01M | $76.30M | $105.97M |
| Revenue growth (YoY) | — | +478.4% | +14.0% | +370.2% | +2.4% | -44.3% | +31.8% | -31.5% | +1446.0% | -81.6% | +0.4% | +38.9% |
| Cost of revenue | $10.47M | $24.40M | $35.55M | $41.14M | $56.93M | $117.10M | $170.90M | $199.54M | $208.70M | $142.99M | $11.19M | $10.79M |
| Gross profit | $-8.80M | $-14.74M | $-24.54M | $10.62M | $53.02M | $-87.55M | $38.95M | $26.68M | $412.48M | $-66.98M | $76.30M | $95.17M |
| Gross margin | -527.1% | -152.6% | -222.9% | 20.5% | 100.0% | -296.3% | 100.0% | 100.0% | 100.0% | -88.1% | 100.0% | 89.8% |
| R&D | $12.62M | $24.65M | $36.82M | $41.75M | $56.68M | $118.25M | $168.53M | $199.75M | $208.60M | $143.62M | $134.62M | $137.00M |
| SG&A | $3.94M | $5.22M | $12.55M | $18.55M | $29.46M | $62.71M | $57.88M | $42.56M | $73.36M | $70.40M | $61.50M | $14.19B |
| Operating income | $-12.75M | $-19.96M | $-37.86M | $-9.00M | $-33.13M | $-151.30M | $-187.47M | $-215.63M | $130.53M | $-138.05M | $-137.11M | $-92.55M |
| Operating margin | -763.4% | -206.6% | -343.9% | -17.4% | -62.5% | -512.1% | -481.3% | -808.2% | 31.6% | -181.6% | -179.7% | -87.3% |
| EBITDA | $-12.34M | $-18.62M | $-36.26M | $-6.08M | $-29.50M | $-148.12M | $-177.19M | $-206.05M | $142.53M | $-120.70M | $-108.62M | $7.65B |
| EBITDA margin | -738.7% | -192.8% | -329.4% | -11.8% | -55.6% | -501.3% | -454.9% | -772.3% | 34.6% | -158.8% | -142.4% | 7214.9% |
| EBIT | $-12.75M | $-19.12M | $-37.28M | $-8.82M | $-33.13M | $-150.43M | $-187.47M | $-215.63M | $130.53M | $-138.01M | $-119.82M | $-79.75M |
| Interest expense | $9000.00 | $18000.00 | $950000.00 | $1.14M | $166000.00 | $11.08M | $17.62M | $12.86M | $3.60M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-12.94M | $-19.17M | $-33.81M | $-10.41M | $-36.56M | $-145.44M | $-180.55M | $-211.84M | $124.34M | $-118.67M | $-122.69M | $-81.13M |
| Net income growth (YoY) | — | -48.1% | -76.4% | +69.2% | -251.3% | -297.8% | -24.1% | -17.3% | +158.7% | -195.4% | -3.4% | +33.9% |
| Profit margin | -775.0% | -198.4% | -307.1% | -20.1% | -68.9% | -492.3% | -463.5% | -794.0% | 30.1% | -156.1% | -160.8% | -76.6% |